nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2D6—Hydroxyurea—head and neck cancer	0.204	0.354	CbGbCtD
Almotriptan—CYP2C8—Fluorouracil—head and neck cancer	0.122	0.212	CbGbCtD
Almotriptan—CYP1A2—Fluorouracil—head and neck cancer	0.0946	0.164	CbGbCtD
Almotriptan—CYP2D6—Vinblastine—head and neck cancer	0.0722	0.125	CbGbCtD
Almotriptan—CYP3A4—Vinblastine—head and neck cancer	0.0459	0.0796	CbGbCtD
Almotriptan—CYP3A4—Docetaxel—head and neck cancer	0.0378	0.0656	CbGbCtD
Almotriptan—Arteriospasm coronary—Fluorouracil—head and neck cancer	0.0209	0.0805	CcSEcCtD
Almotriptan—Ischaemia—Vinblastine—head and neck cancer	0.0127	0.0487	CcSEcCtD
Almotriptan—HTR1B—trigeminal nerve—head and neck cancer	0.0124	0.185	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—head and neck cancer	0.012	0.179	CbGeAlD
Almotriptan—HTR1B—cranial nerve—head and neck cancer	0.00886	0.132	CbGeAlD
Almotriptan—HTR1D—cranial nerve—head and neck cancer	0.00858	0.127	CbGeAlD
Almotriptan—Colitis ischaemic—Docetaxel—head and neck cancer	0.00745	0.0287	CcSEcCtD
Almotriptan—Nystagmus—Vinblastine—head and neck cancer	0.00647	0.0249	CcSEcCtD
Almotriptan—Nystagmus—Fluorouracil—head and neck cancer	0.00425	0.0163	CcSEcCtD
Almotriptan—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00377	0.0145	CcSEcCtD
Almotriptan—Eye irritation—Fluorouracil—head and neck cancer	0.00355	0.0137	CcSEcCtD
Almotriptan—FMO3—parotid gland—head and neck cancer	0.00354	0.0526	CbGeAlD
Almotriptan—Parosmia—Docetaxel—head and neck cancer	0.00338	0.013	CcSEcCtD
Almotriptan—Scotoma—Docetaxel—head and neck cancer	0.00288	0.0111	CcSEcCtD
Almotriptan—Angina pectoris—Vinblastine—head and neck cancer	0.00283	0.0109	CcSEcCtD
Almotriptan—Otitis media—Docetaxel—head and neck cancer	0.00281	0.0108	CcSEcCtD
Almotriptan—Breast disorder—Hydroxyurea—head and neck cancer	0.00277	0.0106	CcSEcCtD
Almotriptan—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00272	0.0105	CcSEcCtD
Almotriptan—Euphoric mood—Fluorouracil—head and neck cancer	0.00261	0.01	CcSEcCtD
Almotriptan—Eye irritation—Docetaxel—head and neck cancer	0.00256	0.00987	CcSEcCtD
Almotriptan—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00255	0.00981	CcSEcCtD
Almotriptan—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00253	0.00975	CcSEcCtD
Almotriptan—Myocardial infarction—Vinblastine—head and neck cancer	0.00253	0.00975	CcSEcCtD
Almotriptan—Bone disorder—Docetaxel—head and neck cancer	0.00242	0.00933	CcSEcCtD
Almotriptan—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00231	0.00889	CcSEcCtD
Almotriptan—Hypoaesthesia—Vinblastine—head and neck cancer	0.00231	0.00889	CcSEcCtD
Almotriptan—Pharyngitis—Vinblastine—head and neck cancer	0.0023	0.00886	CcSEcCtD
Almotriptan—Colitis—Docetaxel—head and neck cancer	0.0021	0.00809	CcSEcCtD
Almotriptan—FMO3—thyroid gland—head and neck cancer	0.00207	0.0307	CbGeAlD
Almotriptan—Neuropathy—Docetaxel—head and neck cancer	0.00206	0.00791	CcSEcCtD
Almotriptan—Muscular weakness—Fluorouracil—head and neck cancer	0.00194	0.00747	CcSEcCtD
Almotriptan—Chills—Hydroxyurea—head and neck cancer	0.0019	0.00731	CcSEcCtD
Almotriptan—MAOA—neck—head and neck cancer	0.00188	0.0279	CbGeAlD
Almotriptan—Ill-defined disorder—Vinblastine—head and neck cancer	0.00187	0.00721	CcSEcCtD
Almotriptan—Angina pectoris—Fluorouracil—head and neck cancer	0.00185	0.00714	CcSEcCtD
Almotriptan—Erythema—Hydroxyurea—head and neck cancer	0.00184	0.00709	CcSEcCtD
Almotriptan—FMO3—head—head and neck cancer	0.00184	0.0273	CbGeAlD
Almotriptan—Malaise—Vinblastine—head and neck cancer	0.00182	0.00701	CcSEcCtD
Almotriptan—Vertigo—Vinblastine—head and neck cancer	0.00182	0.00699	CcSEcCtD
Almotriptan—HTR1D—connective tissue—head and neck cancer	0.00177	0.0263	CbGeAlD
Almotriptan—Convulsion—Vinblastine—head and neck cancer	0.00175	0.00674	CcSEcCtD
Almotriptan—Hypertension—Vinblastine—head and neck cancer	0.00174	0.00671	CcSEcCtD
Almotriptan—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00174	0.00669	CcSEcCtD
Almotriptan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00171	0.00658	CcSEcCtD
Almotriptan—Discomfort—Vinblastine—head and neck cancer	0.0017	0.00654	CcSEcCtD
Almotriptan—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00167	0.00644	CcSEcCtD
Almotriptan—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00166	0.0064	CcSEcCtD
Almotriptan—Myocardial infarction—Fluorouracil—head and neck cancer	0.00166	0.0064	CcSEcCtD
Almotriptan—Malaise—Hydroxyurea—head and neck cancer	0.00166	0.00639	CcSEcCtD
Almotriptan—Conjunctivitis—Fluorouracil—head and neck cancer	0.00165	0.00635	CcSEcCtD
Almotriptan—Epistaxis—Fluorouracil—head and neck cancer	0.0016	0.00616	CcSEcCtD
Almotriptan—Convulsion—Hydroxyurea—head and neck cancer	0.0016	0.00614	CcSEcCtD
Almotriptan—Sinusitis—Fluorouracil—head and neck cancer	0.00159	0.00613	CcSEcCtD
Almotriptan—Pain in extremity—Docetaxel—head and neck cancer	0.00159	0.00612	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00156	0.00599	CcSEcCtD
Almotriptan—Discomfort—Hydroxyurea—head and neck cancer	0.00155	0.00596	CcSEcCtD
Almotriptan—MAOA—parotid gland—head and neck cancer	0.00153	0.0227	CbGeAlD
Almotriptan—Rhinitis—Fluorouracil—head and neck cancer	0.00153	0.00588	CcSEcCtD
Almotriptan—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00152	0.00583	CcSEcCtD
Almotriptan—Pharyngitis—Fluorouracil—head and neck cancer	0.00151	0.00582	CcSEcCtD
Almotriptan—Paraesthesia—Vinblastine—head and neck cancer	0.00148	0.0057	CcSEcCtD
Almotriptan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00148	0.00568	CcSEcCtD
Almotriptan—MAOA—saliva-secreting gland—head and neck cancer	0.00147	0.0218	CbGeAlD
Almotriptan—Skin disorder—Hydroxyurea—head and neck cancer	0.00146	0.00562	CcSEcCtD
Almotriptan—Abdominal pain upper—Docetaxel—head and neck cancer	0.00145	0.00559	CcSEcCtD
Almotriptan—Breast disorder—Docetaxel—head and neck cancer	0.00144	0.00553	CcSEcCtD
Almotriptan—Pain—Vinblastine—head and neck cancer	0.00141	0.00543	CcSEcCtD
Almotriptan—Feeling abnormal—Vinblastine—head and neck cancer	0.00136	0.00523	CcSEcCtD
Almotriptan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00135	0.00519	CcSEcCtD
Almotriptan—MAOA—connective tissue—head and neck cancer	0.00135	0.02	CbGeAlD
Almotriptan—Dyspnoea—Hydroxyurea—head and neck cancer	0.00134	0.00516	CcSEcCtD
Almotriptan—Angina pectoris—Docetaxel—head and neck cancer	0.00134	0.00515	CcSEcCtD
Almotriptan—Somnolence—Hydroxyurea—head and neck cancer	0.00134	0.00514	CcSEcCtD
Almotriptan—Erythema—Fluorouracil—head and neck cancer	0.00133	0.0051	CcSEcCtD
Almotriptan—Dyspepsia—Hydroxyurea—head and neck cancer	0.00132	0.00509	CcSEcCtD
Almotriptan—Abdominal pain—Vinblastine—head and neck cancer	0.0013	0.00502	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.0013	0.005	CcSEcCtD
Almotriptan—Fatigue—Hydroxyurea—head and neck cancer	0.0013	0.00499	CcSEcCtD
Almotriptan—Pain—Hydroxyurea—head and neck cancer	0.00129	0.00495	CcSEcCtD
Almotriptan—FMO3—lymph node—head and neck cancer	0.00129	0.0191	CbGeAlD
Almotriptan—Vision blurred—Fluorouracil—head and neck cancer	0.00125	0.00481	CcSEcCtD
Almotriptan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00124	0.00477	CcSEcCtD
Almotriptan—Hypersensitivity—Vinblastine—head and neck cancer	0.00122	0.00468	CcSEcCtD
Almotriptan—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00121	0.00465	CcSEcCtD
Almotriptan—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0012	0.00462	CcSEcCtD
Almotriptan—Myocardial infarction—Docetaxel—head and neck cancer	0.0012	0.00462	CcSEcCtD
Almotriptan—Conjunctivitis—Docetaxel—head and neck cancer	0.00119	0.00458	CcSEcCtD
Almotriptan—Body temperature increased—Hydroxyurea—head and neck cancer	0.00119	0.00457	CcSEcCtD
Almotriptan—Asthenia—Vinblastine—head and neck cancer	0.00118	0.00455	CcSEcCtD
Almotriptan—Epistaxis—Docetaxel—head and neck cancer	0.00116	0.00445	CcSEcCtD
Almotriptan—Convulsion—Fluorouracil—head and neck cancer	0.00115	0.00442	CcSEcCtD
Almotriptan—MAOA—trachea—head and neck cancer	0.00113	0.0168	CbGeAlD
Almotriptan—Chest pain—Fluorouracil—head and neck cancer	0.00113	0.00435	CcSEcCtD
Almotriptan—Myalgia—Fluorouracil—head and neck cancer	0.00113	0.00435	CcSEcCtD
Almotriptan—Diarrhoea—Vinblastine—head and neck cancer	0.00113	0.00434	CcSEcCtD
Almotriptan—Discomfort—Fluorouracil—head and neck cancer	0.00112	0.00429	CcSEcCtD
Almotriptan—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00111	0.00426	CcSEcCtD
Almotriptan—Rhinitis—Docetaxel—head and neck cancer	0.0011	0.00424	CcSEcCtD
Almotriptan—Hypoaesthesia—Docetaxel—head and neck cancer	0.00109	0.00421	CcSEcCtD
Almotriptan—Confusional state—Fluorouracil—head and neck cancer	0.00109	0.0042	CcSEcCtD
Almotriptan—Pharyngitis—Docetaxel—head and neck cancer	0.00109	0.0042	CcSEcCtD
Almotriptan—Dizziness—Vinblastine—head and neck cancer	0.00109	0.0042	CcSEcCtD
Almotriptan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00108	0.00417	CcSEcCtD
Almotriptan—Asthenia—Hydroxyurea—head and neck cancer	0.00108	0.00415	CcSEcCtD
Almotriptan—HTR1B—head—head and neck cancer	0.00108	0.016	CbGeAlD
Almotriptan—Nervous system disorder—Fluorouracil—head and neck cancer	0.00106	0.00408	CcSEcCtD
Almotriptan—Visual impairment—Docetaxel—head and neck cancer	0.00106	0.00408	CcSEcCtD
Almotriptan—Tachycardia—Fluorouracil—head and neck cancer	0.00106	0.00407	CcSEcCtD
Almotriptan—Vomiting—Vinblastine—head and neck cancer	0.00105	0.00403	CcSEcCtD
Almotriptan—HTR1D—head—head and neck cancer	0.00104	0.0155	CbGeAlD
Almotriptan—Headache—Vinblastine—head and neck cancer	0.00103	0.00398	CcSEcCtD
Almotriptan—Diarrhoea—Hydroxyurea—head and neck cancer	0.00103	0.00396	CcSEcCtD
Almotriptan—Eye disorder—Docetaxel—head and neck cancer	0.00103	0.00395	CcSEcCtD
Almotriptan—Cardiac disorder—Docetaxel—head and neck cancer	0.00102	0.00393	CcSEcCtD
Almotriptan—Dizziness—Hydroxyurea—head and neck cancer	0.000995	0.00383	CcSEcCtD
Almotriptan—Immune system disorder—Docetaxel—head and neck cancer	0.000993	0.00382	CcSEcCtD
Almotriptan—Chills—Docetaxel—head and neck cancer	0.000987	0.0038	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000986	0.00379	CcSEcCtD
Almotriptan—Nausea—Vinblastine—head and neck cancer	0.00098	0.00377	CcSEcCtD
Almotriptan—Insomnia—Fluorouracil—head and neck cancer	0.000979	0.00377	CcSEcCtD
Almotriptan—Paraesthesia—Fluorouracil—head and neck cancer	0.000972	0.00374	CcSEcCtD
Almotriptan—Dyspnoea—Fluorouracil—head and neck cancer	0.000965	0.00371	CcSEcCtD
Almotriptan—Mental disorder—Docetaxel—head and neck cancer	0.000964	0.00371	CcSEcCtD
Almotriptan—Somnolence—Fluorouracil—head and neck cancer	0.000962	0.0037	CcSEcCtD
Almotriptan—Erythema—Docetaxel—head and neck cancer	0.000957	0.00368	CcSEcCtD
Almotriptan—Vomiting—Hydroxyurea—head and neck cancer	0.000956	0.00368	CcSEcCtD
Almotriptan—Dyspepsia—Fluorouracil—head and neck cancer	0.000953	0.00367	CcSEcCtD
Almotriptan—Rash—Hydroxyurea—head and neck cancer	0.000948	0.00365	CcSEcCtD
Almotriptan—Dermatitis—Hydroxyurea—head and neck cancer	0.000947	0.00365	CcSEcCtD
Almotriptan—Headache—Hydroxyurea—head and neck cancer	0.000942	0.00363	CcSEcCtD
Almotriptan—Dysgeusia—Docetaxel—head and neck cancer	0.000938	0.00361	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000935	0.0036	CcSEcCtD
Almotriptan—Back pain—Docetaxel—head and neck cancer	0.000926	0.00356	CcSEcCtD
Almotriptan—Pain—Fluorouracil—head and neck cancer	0.000926	0.00356	CcSEcCtD
Almotriptan—MAOA—thyroid gland—head and neck cancer	0.000895	0.0133	CbGeAlD
Almotriptan—Nausea—Hydroxyurea—head and neck cancer	0.000893	0.00344	CcSEcCtD
Almotriptan—Feeling abnormal—Fluorouracil—head and neck cancer	0.000892	0.00343	CcSEcCtD
Almotriptan—Syncope—Docetaxel—head and neck cancer	0.000859	0.0033	CcSEcCtD
Almotriptan—Body temperature increased—Fluorouracil—head and neck cancer	0.000856	0.00329	CcSEcCtD
Almotriptan—Palpitations—Docetaxel—head and neck cancer	0.000846	0.00326	CcSEcCtD
Almotriptan—Loss of consciousness—Docetaxel—head and neck cancer	0.000842	0.00324	CcSEcCtD
Almotriptan—Convulsion—Docetaxel—head and neck cancer	0.00083	0.00319	CcSEcCtD
Almotriptan—Hypertension—Docetaxel—head and neck cancer	0.000827	0.00318	CcSEcCtD
Almotriptan—Myalgia—Docetaxel—head and neck cancer	0.000815	0.00314	CcSEcCtD
Almotriptan—Arthralgia—Docetaxel—head and neck cancer	0.000815	0.00314	CcSEcCtD
Almotriptan—Chest pain—Docetaxel—head and neck cancer	0.000815	0.00314	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00081	0.00311	CcSEcCtD
Almotriptan—Hypersensitivity—Fluorouracil—head and neck cancer	0.000798	0.00307	CcSEcCtD
Almotriptan—Dry mouth—Docetaxel—head and neck cancer	0.000797	0.00307	CcSEcCtD
Almotriptan—MAOA—head—head and neck cancer	0.000794	0.0118	CbGeAlD
Almotriptan—Confusional state—Docetaxel—head and neck cancer	0.000788	0.00303	CcSEcCtD
Almotriptan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000781	0.00301	CcSEcCtD
Almotriptan—Shock—Docetaxel—head and neck cancer	0.000769	0.00296	CcSEcCtD
Almotriptan—Nervous system disorder—Docetaxel—head and neck cancer	0.000766	0.00295	CcSEcCtD
Almotriptan—Pruritus—Fluorouracil—head and neck cancer	0.000766	0.00295	CcSEcCtD
Almotriptan—Tachycardia—Docetaxel—head and neck cancer	0.000763	0.00293	CcSEcCtD
Almotriptan—Skin disorder—Docetaxel—head and neck cancer	0.000759	0.00292	CcSEcCtD
Almotriptan—CYP1A2—thyroid gland—head and neck cancer	0.000747	0.0111	CbGeAlD
Almotriptan—Diarrhoea—Fluorouracil—head and neck cancer	0.000741	0.00285	CcSEcCtD
Almotriptan—CYP2E1—lymphoid tissue—head and neck cancer	0.00074	0.011	CbGeAlD
Almotriptan—Dizziness—Fluorouracil—head and neck cancer	0.000716	0.00275	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000712	0.00274	CcSEcCtD
Almotriptan—Insomnia—Docetaxel—head and neck cancer	0.000707	0.00272	CcSEcCtD
Almotriptan—Paraesthesia—Docetaxel—head and neck cancer	0.000702	0.0027	CcSEcCtD
Almotriptan—Dyspnoea—Docetaxel—head and neck cancer	0.000697	0.00268	CcSEcCtD
Almotriptan—Somnolence—Docetaxel—head and neck cancer	0.000695	0.00267	CcSEcCtD
Almotriptan—Vomiting—Fluorouracil—head and neck cancer	0.000688	0.00265	CcSEcCtD
Almotriptan—Dyspepsia—Docetaxel—head and neck cancer	0.000688	0.00265	CcSEcCtD
Almotriptan—Rash—Fluorouracil—head and neck cancer	0.000683	0.00263	CcSEcCtD
Almotriptan—Dermatitis—Fluorouracil—head and neck cancer	0.000682	0.00262	CcSEcCtD
Almotriptan—Headache—Fluorouracil—head and neck cancer	0.000678	0.00261	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000675	0.0026	CcSEcCtD
Almotriptan—Fatigue—Docetaxel—head and neck cancer	0.000674	0.00259	CcSEcCtD
Almotriptan—CYP2E1—thyroid gland—head and neck cancer	0.000672	0.00997	CbGeAlD
Almotriptan—Pain—Docetaxel—head and neck cancer	0.000668	0.00257	CcSEcCtD
Almotriptan—Feeling abnormal—Docetaxel—head and neck cancer	0.000644	0.00248	CcSEcCtD
Almotriptan—Nausea—Fluorouracil—head and neck cancer	0.000643	0.00247	CcSEcCtD
Almotriptan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000639	0.00246	CcSEcCtD
Almotriptan—Abdominal pain—Docetaxel—head and neck cancer	0.000618	0.00238	CcSEcCtD
Almotriptan—Body temperature increased—Docetaxel—head and neck cancer	0.000618	0.00238	CcSEcCtD
Almotriptan—CYP2E1—head—head and neck cancer	0.000596	0.00885	CbGeAlD
Almotriptan—Hypersensitivity—Docetaxel—head and neck cancer	0.000576	0.00221	CcSEcCtD
Almotriptan—Asthenia—Docetaxel—head and neck cancer	0.000561	0.00216	CcSEcCtD
Almotriptan—Melatonin—CYP1A1—head and neck cancer	0.000559	1	CrCbGaD
Almotriptan—MAOA—lymph node—head and neck cancer	0.000556	0.00826	CbGeAlD
Almotriptan—Pruritus—Docetaxel—head and neck cancer	0.000553	0.00213	CcSEcCtD
Almotriptan—Diarrhoea—Docetaxel—head and neck cancer	0.000535	0.00206	CcSEcCtD
Almotriptan—Dizziness—Docetaxel—head and neck cancer	0.000517	0.00199	CcSEcCtD
Almotriptan—Vomiting—Docetaxel—head and neck cancer	0.000497	0.00191	CcSEcCtD
Almotriptan—Rash—Docetaxel—head and neck cancer	0.000493	0.0019	CcSEcCtD
Almotriptan—Dermatitis—Docetaxel—head and neck cancer	0.000492	0.00189	CcSEcCtD
Almotriptan—Headache—Docetaxel—head and neck cancer	0.00049	0.00188	CcSEcCtD
Almotriptan—CYP2D6—head—head and neck cancer	0.000472	0.00701	CbGeAlD
Almotriptan—Nausea—Docetaxel—head and neck cancer	0.000464	0.00179	CcSEcCtD
Almotriptan—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000375	0.00393	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.00037	0.00388	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—GRP—head and neck cancer	0.000368	0.00386	CbGpPWpGaD
Almotriptan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000364	0.00382	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—GRP—head and neck cancer	0.000361	0.00378	CbGpPWpGaD
Almotriptan—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000359	0.00377	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000351	0.00368	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000351	0.00368	CbGpPWpGaD
Almotriptan—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000351	0.00368	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000351	0.00368	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—GSTM1—head and neck cancer	0.00035	0.00366	CbGpPWpGaD
Almotriptan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000335	0.00351	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000335	0.00351	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000332	0.00347	CbGpPWpGaD
Almotriptan—MAOA—Biological oxidations—CYP1A1—head and neck cancer	0.000331	0.00347	CbGpPWpGaD
Almotriptan—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000331	0.00347	CbGpPWpGaD
Almotriptan—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000331	0.00346	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.00033	0.00346	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000328	0.00344	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000308	0.00323	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000304	0.00318	CbGpPWpGaD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000295	0.00309	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—UROD—head and neck cancer	0.000291	0.00305	CbGpPWpGaD
Almotriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000284	0.00297	CbGpPWpGaD
Almotriptan—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000281	0.00294	CbGpPWpGaD
Almotriptan—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00028	0.00293	CbGpPWpGaD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000272	0.00284	CbGpPWpGaD
Almotriptan—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000271	0.00284	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000261	0.00273	CbGpPWpGaD
Almotriptan—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00026	0.00272	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000257	0.0027	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—NAT2—head and neck cancer	0.000253	0.00265	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—KISS1—head and neck cancer	0.000253	0.00265	CbGpPWpGaD
Almotriptan—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000251	0.00263	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—KISS1—head and neck cancer	0.000248	0.00259	CbGpPWpGaD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00023	0.00241	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—KISS1—head and neck cancer	0.00023	0.00241	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—KISS1—head and neck cancer	0.000225	0.00236	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—DPYD—head and neck cancer	0.000222	0.00233	CbGpPWpGaD
Almotriptan—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.00022	0.00231	CbGpPWpGaD
Almotriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000219	0.00229	CbGpPWpGaD
Almotriptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000216	0.00226	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000214	0.00225	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000211	0.00222	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—YAP1—head and neck cancer	0.000211	0.00221	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000209	0.00219	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—GRP—head and neck cancer	0.000208	0.00218	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—GRP—head and neck cancer	0.000204	0.00214	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000203	0.00213	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000201	0.00211	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.0002	0.0021	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000199	0.00208	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000195	0.00205	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000193	0.00203	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—GRP—head and neck cancer	0.000189	0.00198	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000185	0.00194	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—GRP—head and neck cancer	0.000185	0.00194	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000183	0.00192	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—UROD—head and neck cancer	0.000179	0.00187	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000178	0.00186	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000176	0.00184	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000173	0.00182	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000168	0.00176	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000165	0.00173	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000164	0.00172	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000163	0.00171	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000157	0.00164	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000155	0.00162	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—UROD—head and neck cancer	0.000155	0.00162	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000152	0.00159	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.00015	0.00157	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000148	0.00155	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000148	0.00155	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000148	0.00155	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000144	0.00151	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000142	0.00149	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—UROD—head and neck cancer	0.000138	0.00145	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KISS1—head and neck cancer	0.000136	0.00142	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KISS1—head and neck cancer	0.000133	0.00139	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000129	0.00135	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000127	0.00133	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—UROD—head and neck cancer	0.000127	0.00133	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—TYMS—head and neck cancer	0.000127	0.00133	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTM1—head and neck cancer	0.000125	0.00131	CbGpPWpGaD
Almotriptan—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000124	0.0013	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000122	0.00128	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NAT2—head and neck cancer	0.000121	0.00127	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000121	0.00126	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00012	0.00126	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GPX1—head and neck cancer	0.00012	0.00125	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000119	0.00124	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP1A1—head and neck cancer	0.000119	0.00124	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GRP—head and neck cancer	0.000112	0.00117	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GRP—head and neck cancer	0.000109	0.00115	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT6—head and neck cancer	0.000108	0.00114	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—UROD—head and neck cancer	0.000107	0.00113	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000107	0.00112	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT6—head and neck cancer	0.000106	0.00111	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—DPYD—head and neck cancer	0.000106	0.00111	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—YAP1—head and neck cancer	0.000101	0.00105	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.95e-05	0.00104	CbGpPWpGaD
Almotriptan—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	9.94e-05	0.00104	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.81e-05	0.00103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—YAP1—head and neck cancer	9.6e-05	0.00101	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—MAPK1—head and neck cancer	9.49e-05	0.000994	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	9.43e-05	0.000988	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—YAP1—head and neck cancer	9.4e-05	0.000984	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	9.3e-05	0.000974	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.34e-05	0.000874	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—UROD—head and neck cancer	8.3e-05	0.000869	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—HRAS—head and neck cancer	7.62e-05	0.000798	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NAT2—head and neck cancer	7.42e-05	0.000778	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTGS2—head and neck cancer	7.05e-05	0.000739	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.82e-05	0.000714	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.75e-05	0.000707	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—DPYD—head and neck cancer	6.51e-05	0.000682	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NAT2—head and neck cancer	6.42e-05	0.000672	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—YAP1—head and neck cancer	6.18e-05	0.000647	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTEN—head and neck cancer	6.15e-05	0.000644	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.08e-05	0.000637	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TYMS—head and neck cancer	6.05e-05	0.000633	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.02e-05	0.000631	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTM1—head and neck cancer	5.98e-05	0.000626	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NAT2—head and neck cancer	5.73e-05	0.0006	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GPX1—head and neck cancer	5.72e-05	0.0006	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1A1—head and neck cancer	5.67e-05	0.000594	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—DPYD—head and neck cancer	5.63e-05	0.00059	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—head and neck cancer	5.55e-05	0.000581	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—head and neck cancer	5.43e-05	0.000569	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—YAP1—head and neck cancer	5.34e-05	0.000559	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NAT2—head and neck cancer	5.27e-05	0.000552	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—head and neck cancer	5.04e-05	0.000528	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—DPYD—head and neck cancer	5.02e-05	0.000526	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—head and neck cancer	4.93e-05	0.000517	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—YAP1—head and neck cancer	4.77e-05	0.000499	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.74e-05	0.000497	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.69e-05	0.000492	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—DPYD—head and neck cancer	4.62e-05	0.000484	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NAT2—head and neck cancer	4.46e-05	0.000468	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—YAP1—head and neck cancer	4.38e-05	0.000459	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—head and neck cancer	4.34e-05	0.000454	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH1—head and neck cancer	4.32e-05	0.000453	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH1—head and neck cancer	4.23e-05	0.000444	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK3—head and neck cancer	4.05e-05	0.000424	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.01e-05	0.00042	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—head and neck cancer	3.97e-05	0.000415	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—DPYD—head and neck cancer	3.91e-05	0.00041	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK1—head and neck cancer	3.85e-05	0.000404	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—head and neck cancer	3.85e-05	0.000404	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK1—head and neck cancer	3.77e-05	0.000395	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—head and neck cancer	3.77e-05	0.000395	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—YAP1—head and neck cancer	3.71e-05	0.000389	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TYMS—head and neck cancer	3.71e-05	0.000389	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—head and neck cancer	3.68e-05	0.000386	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—head and neck cancer	3.67e-05	0.000384	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—head and neck cancer	3.61e-05	0.000378	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.58e-05	0.000375	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—head and neck cancer	3.54e-05	0.000371	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—head and neck cancer	3.51e-05	0.000368	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.5e-05	0.000367	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A1—head and neck cancer	3.48e-05	0.000364	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NAT2—head and neck cancer	3.44e-05	0.000361	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—head and neck cancer	3.37e-05	0.000353	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—head and neck cancer	3.34e-05	0.00035	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—head and neck cancer	3.27e-05	0.000343	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMS—head and neck cancer	3.21e-05	0.000336	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.17e-05	0.000332	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.12e-05	0.000327	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HRAS—head and neck cancer	3.09e-05	0.000324	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—head and neck cancer	3.04e-05	0.000318	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HRAS—head and neck cancer	3.03e-05	0.000317	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—DPYD—head and neck cancer	3.02e-05	0.000316	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—head and neck cancer	3.01e-05	0.000315	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3e-05	0.000315	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—head and neck cancer	2.98e-05	0.000312	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—head and neck cancer	2.95e-05	0.000309	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTEN—head and neck cancer	2.94e-05	0.000308	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—head and neck cancer	2.91e-05	0.000305	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—head and neck cancer	2.9e-05	0.000304	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—YAP1—head and neck cancer	2.87e-05	0.0003	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMS—head and neck cancer	2.86e-05	0.0003	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—head and neck cancer	2.84e-05	0.000298	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.83e-05	0.000296	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTEN—head and neck cancer	2.8e-05	0.000293	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.79e-05	0.000292	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTEN—head and neck cancer	2.74e-05	0.000287	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—head and neck cancer	2.73e-05	0.000286	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—head and neck cancer	2.71e-05	0.000284	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.68e-05	0.000281	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—head and neck cancer	2.68e-05	0.00028	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMS—head and neck cancer	2.63e-05	0.000276	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.6e-05	0.000273	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—head and neck cancer	2.53e-05	0.000265	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—head and neck cancer	2.5e-05	0.000262	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—head and neck cancer	2.49e-05	0.000261	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—head and neck cancer	2.48e-05	0.000259	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.47e-05	0.000259	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.47e-05	0.000258	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—head and neck cancer	2.45e-05	0.000257	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.43e-05	0.000255	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—head and neck cancer	2.39e-05	0.000251	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—head and neck cancer	2.34e-05	0.000245	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK1—head and neck cancer	2.28e-05	0.000239	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—head and neck cancer	2.28e-05	0.000238	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMS—head and neck cancer	2.23e-05	0.000234	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK1—head and neck cancer	2.23e-05	0.000234	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—head and neck cancer	2.23e-05	0.000233	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.2e-05	0.000231	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.2e-05	0.000231	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—head and neck cancer	2.11e-05	0.000221	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.09e-05	0.000219	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—head and neck cancer	2.07e-05	0.000217	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—head and neck cancer	2.07e-05	0.000217	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.98e-05	0.000207	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	1.93e-05	0.000203	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.91e-05	0.0002	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—head and neck cancer	1.87e-05	0.000196	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.83e-05	0.000191	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTEN—head and neck cancer	1.8e-05	0.000189	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HRAS—head and neck cancer	1.79e-05	0.000187	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.79e-05	0.000187	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMS—head and neck cancer	1.72e-05	0.00018	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.72e-05	0.00018	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.7e-05	0.000178	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—head and neck cancer	1.69e-05	0.000177	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—head and neck cancer	1.63e-05	0.000171	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—head and neck cancer	1.61e-05	0.000169	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.61e-05	0.000169	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.6e-05	0.000167	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—head and neck cancer	1.58e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTEN—head and neck cancer	1.56e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.47e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTEN—head and neck cancer	1.39e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTEN—head and neck cancer	1.28e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.27e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.24e-05	0.00013	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.1e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTEN—head and neck cancer	1.08e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—head and neck cancer	1.04e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—head and neck cancer	9.81e-06	0.000103	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—head and neck cancer	9.59e-06	0.0001	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—head and neck cancer	9.03e-06	9.46e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—head and neck cancer	8.98e-06	9.41e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTEN—head and neck cancer	8.36e-06	8.76e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—head and neck cancer	8.02e-06	8.4e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—head and neck cancer	7.65e-06	8.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—head and neck cancer	7.37e-06	7.72e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—head and neck cancer	6.25e-06	6.54e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.9e-06	6.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—head and neck cancer	4.82e-06	5.05e-05	CbGpPWpGaD
